Edema Due To Nephrotic Syndrome — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for edema due to nephrotic syndrome. 9 active patents protecting 2 drugs from 1+ originators. First major cliff: 2044. Daily refresh.

2
Approved drugs
9
Active US patents
63/100
Avg vulnerability
—
Annual revenue covered

Originators in Edema Due To Nephrotic Syndrome

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Searle/Pfizer) 9 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating edema due to nephrotic syndrome. Each bar = one year. Y-axis scaled to peak year (8 patents).

8
36

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Aldactone
spironolactone
 Generic (originally Searle/Pfizer) 8 50 — 2036-10-28
Microzide
hydrochlorothiazide
 Generic (originally Merck) 1 75 — 2044-01-23

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11878022 Microzide method of use 75 2044-01-23
11395828 Aldactone method of use 70 2036-10-28
9757394 Aldactone method of use 62 2036-10-28
11389461 Aldactone formulation 50 2036-10-28
11491166 Aldactone formulation 50 2036-10-28
10624906 Aldactone formulation 42 2036-10-28
10493083 Aldactone formulation 42 2036-10-28
10660907 Aldactone formulation 42 2036-10-28
10888570 Aldactone formulation 42 2036-10-28

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10493083 Aldactone formulation 42 2036-10-28
10660907 Aldactone formulation 42 2036-10-28
10624906 Aldactone formulation 42 2036-10-28
10888570 Aldactone formulation 42 2036-10-28
11389461 Aldactone formulation 50 2036-10-28
11491166 Aldactone formulation 50 2036-10-28
9757394 Aldactone method of use 62 2036-10-28
11395828 Aldactone method of use 70 2036-10-28
11878022 Microzide method of use 75 2044-01-23

Related